Welcome to the working week. We hope your weekend was pleasant, although there was a great deal of shoveling in some parts. Good exercise, yes? Meanwhile, this is a short week for many due to the pending holiday. Nonetheless, this means a flurry of year-end deadlines and meetings. So as you brace yourself for the rush, here are a few items to ease the way. Have a good day, everyone...
Sanofi-Aventis Buys Chattem For $1.9 Billion (Reuters)
Sanofi-Aventis Stops Development Of Two Meds (Bloomberg News)
Actelion Sleep Drugs Has Safety Issues (The Wall Street Journal)
Pfizer Acquires A Stem Cell Therapy (The New York Times)
Glaxo Considers Building UK Facility (Teesdale Mercury)
Pfizer Gives Update On Contaminated Site (The New Haven Register)
Coffee courtesy of Flickr Creative Commons chichcacha
1 Comment
Merry Christmas and Happy New Year to the Pharmalot readers...